Africa CDC Delegation Visits BIBP

On December 17, a delegation from the Africa CDC, led by Director Jean Kaseya and accompanied by Wang Lili, Associate Researcher at the Global Public Health Center of the Chinese Center for Disease Control and Prevention, along with a group of 12 people, visited the Beijing Institute of Biological Products Co., Ltd. (BIBP), part of the China National Biotec Group Company Limited (CNBG). The event was attended by Yang Yang, Director of the International Cooperation Department of China National Pharmaceutical Group Co., Ltd. (Sinopharm Group), Zhang Yuntao, Vice President of CNBG, Zhou Song, Chairman of China Sinopharm International Corporation , and Gao Song, Secretary of the Party Committee of BIBP.

▲Jean Kaseya and his delegation visited CNBG’s Products Museum

The Africa CDC delegation first visited CNBG’s Product Museum and the production workshop of the Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains (sIPV), gaining an in-depth understanding of CNBG’s development history, scientific research products, and vaccine production processes.

▲ Jean Kaseya and his delegation visited the sIPV production workshop

In the subsequent discussion, Zhang Yuntao introduced the progress of CNBG’s vaccine registration, clinical trials, and localized production projects in Africa. He also shared the experience and achievements of cooperation with Africa, as well as the latest developments in the research and development of monkeypox vaccines.

Both sides expressed their intention to further strengthen cooperation in the prevention and control of monkeypox and other infectious diseases. They pledged to jointly promote the development and application of vaccines, production, diagnostic reagents, and therapeutic drugs. Additionally, both sides will actively work towards achieving localized production in Africa to improve the accessibility and affordability of medical products, such as vaccines, and jointly contribute to global efforts in combating infectious diseases.